Zobrazeno 1 - 10
of 611
pro vyhledávání: '"Yasuhide, Yamada"'
Autor:
Hiroyuki Arai, Madoka Takeuchi, Wataru Ichikawa, Kohei Shitara, Yu Sunakawa, Koji Oba, Wasaburo Koizumi, Yuh Sakata, Hiroshi Furukawa, Yasuhide Yamada, Masahiro Takeuchi, Masashi Fujii
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Background Individual‐level surrogates are important for management in patients treated for advanced gastric cancer (AGC). This study aimed to comprehensively investigate the correlation of multiple clinical endpoints in the first‐line c
Externí odkaz:
https://doaj.org/article/5d737d0a98a74cc1afd8f1494ebe7875
Autor:
Satoru Iwasa, Zi‐Xian Wang, Kei Muro, Satoshi Morita, Young Suk Park, Dongsheng Zhang, Yasuhide Yamada, Junichi Sakamoto, Tae Won Kim
Publikováno v:
Cancer Communications, Vol 43, Iss 4, Pp 519-522 (2023)
Externí odkaz:
https://doaj.org/article/8a4d3abd047443ceb9637dd494c11d93
Autor:
Takatoshi Matsuyama, Toshiaki Ishikawa, Naoki Takahashi, Yasuhide Yamada, Masamichi Yasuno, Tatsuyuki Kawano, Hiroyuki Uetake, Ajay Goel
Publikováno v:
Molecular Cancer, Vol 18, Iss 1, Pp 1-7 (2019)
Abstract The current histopathological risk-stratification criteria in colorectal cancer (CRC) patients following a curative surgery remain inadequate. In this study, we undertook a systematic, genomewide, biomarker discovery approach to identify and
Externí odkaz:
https://doaj.org/article/7c4322dd0b0548ef8bcbf08186cf78f8
Autor:
Masato, Karayama, Yukihiro, Mizoguchi, Yusuke, Inoue, Hironao, Hozumi, Yuzo, Suzuki, Kazuki, Furuhashi, Tomoyuki, Fujisawa, Noriyuki, Enomoto, Yutaro, Nakamura, Naoki, Inui, Takafumi, Suda, Shigehisa, Kitano, Kazunori, Aoki, Yasuhide, Yamada
Publikováno v:
Glob Health Med
The occurrence of immune-related adverse events (irAEs) after immune checkpoint inhibitors (ICIs) is unpredictable. Profiles of peripheral blood mononuclear cells (PBMCs) represent the host immune system and have the potential to predict irAEs. We an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff02135355a0ce32f6dde91962cc0704
https://doi.org/10.35772/ghm.2022.01052
https://doi.org/10.35772/ghm.2022.01052
Autor:
Shonosuke Wakayama, Kota Ouchi, Shin Takahashi, Yasuhide Yamada, Yoshito Komatsu, Ken Shimada, Tatsuro Yamaguchi, Hidekazu Shirota, Masanobu Takahashi, Chikashi Ishioka
Publikováno v:
Clinical Colorectal Cancer; Sep2023, Vol. 22 Issue 3, p327-338, 12p
Autor:
Hidekazu Takahashi, Masanobu Takahashi, Shinobu Ohnuma, Michiaki Unno, Yuki Yoshino, Kota Ouchi, Shin Takahashi, Yasuhide Yamada, Hideki Shimodaira, Chikashi Ishioka
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-14 (2017)
Abstract Background The aim of this study was to identify miRNAs specifically dysregulated in BRAF-mutated colorectal cancer, which could lead to a better understanding of the molecular mechanisms underlying oncogenesis of this malignant subtype of c
Externí odkaz:
https://doaj.org/article/4750580dc7dd4571bcd3e593767d7fd4
Autor:
Tetsuya Hamaguchi, Yuji Heike, Narikazu Boku, Naoyuki Katayama, Yasuhide Yamada, Ken Kato, Atsuo Takashima, Natsuko Okita, Satoru Iwasa, Yoshitaka Honma, Nobuyoshi Hiraoka, Kazunori Aoki, Kengo Nagashima, Yasuhiro Shimada, Takashi Nishimura, Hirokazu Shoji, Shigehisa Kitano, Kohei Tada
It remains unclear whether the immunologic status of cells in peripheral blood can be used as a prognostic indicator of response to treatment for patients with unresectable metastatic colorectal cancer (MCRC). We therefore investigated the relationsh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::218ef004c5cd702533ca43980b73c6d5
https://doi.org/10.1158/2326-6066.c.6548681.v1
https://doi.org/10.1158/2326-6066.c.6548681.v1
Autor:
Tetsuya Hamaguchi, Yuji Heike, Narikazu Boku, Naoyuki Katayama, Yasuhide Yamada, Ken Kato, Atsuo Takashima, Natsuko Okita, Satoru Iwasa, Yoshitaka Honma, Nobuyoshi Hiraoka, Kazunori Aoki, Kengo Nagashima, Yasuhiro Shimada, Takashi Nishimura, Hirokazu Shoji, Shigehisa Kitano, Kohei Tada
Supplemental Table 1 Combined assessment of quantities of two values from among M-MDSC, CD4+ TEM, and CD8+ TEM cells for correlation with PFS Supplemental Table 2 Comparison of patient characteristics between Group 1/2 and Group 3/4 Supplemental Tabl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16eea73c3e8de579ec18fe659e26f20f
https://doi.org/10.1158/2326-6066.22538132
https://doi.org/10.1158/2326-6066.22538132
Autor:
Jan H.M. Schellens, Tim Demuth, Kati Maharry, Eugene Tan, Savina Jaeger, Arkendu Chatterjee, Emin Avsar, Zev A. Wainberg, Heinz-Josef Lenz, Rona Yaeger, Sunil Sharma, Ferry A.L.M. Eskens, Jason E. Faris, Martijn P. Lolkema, Yasuhide Yamada, Jean-Pierre Delord, Takayuki Yoshino, Martin Schuler, Anna Spreafico, Johanna C. Bendell, Elena Elez, Josep Tabernero, Robin M.J.M. van Geel
Table S1. Pharmacokinetic parameters of encorafenib and alpelisib in patients at steady state (cycle 2 day 1). Table S2. Criteria for defining dose-limited toxicities. Supplementary Figure 1. Radiological images of response for a patient treated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1341dd8cec12a541df23cf9cbed4ad9b
https://doi.org/10.1158/2159-8290.22532039
https://doi.org/10.1158/2159-8290.22532039
Autor:
Kohei Kamegai, Noriko Iwamoto, Masahiro Ishikane, Kei Yamamoto, Kumi Horii, Shiho Kubota, Akira Hangaishi, Hiroshi Shimazu, Tomiteru Togano, Hiroyuki Yamashita, Yasuhide Yamada, Norio Ohmagari
Publikováno v:
Global Health & Medicine; Dec2023, Vol. 5 Issue 6, p366-371, 6p